Drug major Lupin Ltd has said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients. In a regulatory filing, the company said “the board of directors has approved the company’s entry into the digital healthcare space…”
- Maharashtra Liquor Duty Hike Is a Long-Pending Reform, Says Brewers Association
- Iraq Shuts Airspace After Israel-Iran Conflict; Air India, Lufthansa, Etihad Flights Disrupted
- Arisinfra Solutions IPO GMP: Issue Size, Lot Size, Financials & Timeline
- Meta Invests $14.3 Billion in Scale AI, Hires 28-Year-Old CEO Wang to Lead Superintelligence
- Crompton Greaves Shares Gain on Rs 100 Crore Order Win
The company said it has recently incorporated a new entity in the name of Lupin Digital Health Ltd, as a wholly-owned subsidiary, which will undertake this, the filing added. Lupin, however, did not share any other details about the new venture. Shares of Lupin Ltd were trading 0.29 per cent lower at Rs 1,243.30 apiece on BSE.
Stock Covered in the news
